Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
6.56
-0.19 (-2.81%)
Apr 9, 2026, 3:00 PM CST
15.90% (1Y)
| Market Cap | 4.54B +6.0% |
| Revenue (ttm) | 2.27B -19.7% |
| Net Income | 222.85M +1.0% |
| EPS | 0.32 +4.8% |
| Shares Out | 692.00M |
| PE Ratio | 20.77 |
| Forward PE | n/a |
| Dividend | 0.40 (5.93%) |
| Ex-Dividend Date | Feb 6, 2026 |
| Volume | 30,962,166 |
| Average Volume | 16,635,362 |
| Open | 6.72 |
| Previous Close | 6.75 |
| Day's Range | 6.54 - 6.84 |
| 52-Week Range | 5.35 - 8.68 |
| Beta | 0.11 |
| RSI | 55.21 |
| Earnings Date | Apr 25, 2026 |